VMD
Viemed Healthcare Inc
9.50$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.8% | -91.2% | +766.6% | +25.2% | +17.6% | -81.0% | +329.4% | +49.9% | +0.4% | -56.2% | +97.0% | – | |
| – | -0.9% | +6.2% | +0.4% | +1.6% | -0.7% | +3.9% | +4.2% | +9.4% | +0.4% | +0.7% | -1.3% | – | |
| – | +5.6% | -6.6% | +13.1% | +5.7% | -11.2% | +51.9% | +1.3% | -6.9% | +5.5% | +6.6% | -17.1% | – | |
| – | -14.4% | -409.0% | – | +14,084.5% | -50.6% | -258.8% | – | -107.5% | – | -359.5% | – | – | |
| – | +7.2% | -24.3% | +48.8% | +23.1% | +7.5% | +30.9% | -47.5% | -6.1% | +14.4% | -23.2% | +26.0% | – | |
| – | -11.9% | -28.4% | +108.1% | -55.5% | +85.1% | -7.3% | -79.8% | +1,770.1% | -76.4% | -27.9% | +42.9% | – | |
| – | +2,922.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -96,200.0% | -98.9% | +745.5% | -95.7% | +39,500.0% | +8.0% | +581.6% | -100.0% | +71,850.0% | +269.8% | – | |
| – | – | – | – | – | -97.4% | -3.7% | -5.3% | – | -149.3% | -60.7% | -32.8% | – | |
| – | -44.4% | -55.8% | – | -310.9% | – | -521.8% | -60.6% | – | -267.8% | -25.2% | +13.0% | – | |
| – | – | -300.3% | – | +69.6% | +143.8% | -219.2% | – | -190.2% | – | -257.2% | – | – | |
| – | -16.5% | -190.3% | – | +39.7% | +81.2% | -499.9% | – | +160.1% | -9.6% | -86.0% | +447.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.